Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | THRD | Stock Option (right to buy) | Award | $0 | +16.3K | $0.00 | 16.3K | Jun 6, 2023 | Common Stock | 16.3K | $5.03 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The option will vest in full on the earlier of (a) June 6, 2024 and (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date. |
F2 | The Reporting Person is a member of Atlas Venture Life Science Advisors, LLC ("Atlas") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any. |